# Signals Article on Putative Target Q9NST1 for Non-Alcoholic Steatohepatitis
Background
The protein encoded by the putative target Q9NST1, also known as "Uncharacterized protein," has emerged as a candidate of interest in the study of non-alcoholic steatohepatitis (NASH). Given the increasing incidence of NASH, which is characterized by liver inflammation and damage due to fat accumulation, understanding the role of Q9NST1 may provide new avenues for therapeutic intervention. Preliminary expression profiling studies suggest a potential involvement of Q9NST1 in the pathophysiology of NASH, warranting further investigation into its functional significance.Data-mining rationale
In our analysis, we cross-referenced reviewed human entries from UniProt for "non-alcoholic steatohepatitis" against 49 microarray datasets available in the NCBI Gene Expression Omnibus (GEO). The candidate Q9NST1 was identified in several expression-profiling studies, yet it notably lacks any registered Phase 1 or higher clinical program. This observation raises questions about its potential role in NASH and suggests that it may have been overlooked in previous research.Why prior analyses may have missed this
Many of the GEO datasets utilized in our analysis predate the implementation of modern empirical-Bayes statistical methods, such as the limma package, which allows for more robust multiple-testing corrections. Consequently, the expression data related to Q9NST1 may not have been adequately analyzed, leading to its underappreciation in the context of NASH. The absence of advanced statistical techniques could have obscured significant findings that warrant further exploration.Reasoning for further validation
To substantiate the potential role of Q9NST1 in NASH, we propose the following experimental approaches:1. **Re-analyze matched GEO datasets**: Utilize the limma package with Benjamini-Hochberg false discovery rate (FDR) correction set to < 0.05 to identify differentially expressed genes associated with NASH, including Q9NST1.
2. **Validate top differentially-expressed genes**: Conduct quantitative PCR (qPCR) in an independent cohort to confirm the expression levels of Q9NST1 and other top candidates identified in the re-analysis.
3. **Check tissue specificity**: Utilize resources such as the Genotype-Tissue Expression (GTEx) project and the Human Protein Atlas to assess the tissue-specific expression patterns of Q9NST1, which may provide insights into its functional relevance in liver and metabolic tissues.
4. **Run pathway context analyses**: Employ tools like STRING and OmniPath to elucidate the potential pathways in which Q9NST1 is involved, helping to contextualize its role in NASH.
5. **Assess druggability**: If validation studies confirm the involvement of Q9NST1 in NASH, evaluate its druggability using databases such as DGIdb and ChEMBL to explore potential therapeutic interventions.
References
- UniProt: Q9NST1, Q15848, Q7Z5P4
- GEO Accession: GDS:200200409, GDS:200198961, GDS:200166186, GDS:200195619, GDS:200163211